Alpine Immune Sciences Inc (NAS:ALPN)
$ 64.94 0.12 (0.19%) Market Cap: 4.45 Bil Enterprise Value: 4.16 Bil PE Ratio: 0 PB Ratio: 11.95 GF Score: 61/100

Q2 2021 Alpine Immune Sciences Inc Earnings Call Transcript

Aug 10, 2021 / 08:30PM GMT
Release Date Price: $9.19 (+2.68%)
Operator

(technical difficulty) ladies and gentlemen, and thank you for joining the Alpine Immune Sciences second-quarter 2021 financial results and corporate update conference call. Currently, all participants are in a listen-only mode. (Operator Instructions) As a reminder, this conference is being recorded Tuesday, August 10, 2021.

I would now like to introduce Alex Sharif, Director, Investor Relations and Corporate Development. Please go ahead.

Alex Sharif
Alpine Immune Sciences, Inc. - Director, IR & Corporate Development

Thank you, Mary. With me on today's call from Alpine Immune Sciences are Executive Chairman and CEO, Dr. Mitchell Gold; President and Head of Research and Development, Dr. Stanford Peng; Chief Financial Officer, Paul Rickey; and Chief Business Officer, Dr. Remy Durand.

This afternoon, Alpine Immune Sciences issued a press release announcing the company's second-quarter 2021 financial results and corporate update. If you have not received this news release and would like to read it or if you would simply like to be added to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot